Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Interest & Investment Income (2023 - 2025)

Phibro Animal Health (PAHC) has 6 years of Interest & Investment Income data on record, last reported at -$12.1 million in Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 57.82% year-over-year to -$12.1 million; the TTM value through Sep 2025 reached -$14.8 million, down 193.54%, while the annual FY2025 figure was -$34.6 million, N/A changed from the prior year.
  • Interest & Investment Income reached -$12.1 million in Q3 2025 per PAHC's latest filing, down from $9.5 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $9.5 million in Q4 2024 and bottomed at -$12.1 million in Q3 2025.
  • Average Interest & Investment Income over 3 years is -$3.7 million, with a median of -$6.1 million recorded in 2023.
  • Peak YoY movement for Interest & Investment Income: surged 304.92% in 2024, then crashed 57.82% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at -$4.7 million in 2023, then soared by 304.92% to $9.5 million in 2024, then plummeted by 226.31% to -$12.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest & Investment Income were -$12.1 million in Q3 2025, $9.5 million in Q4 2024, and -$7.6 million in Q3 2024.